Trexquant Investment LP Biocryst Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$8.01 Billion
Q1 2025

A detailed history of Trexquant Investment LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Trexquant Investment LP holds 389,392 shares of BCRX stock, worth $4.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

389,392

Previous 494,356 21.23%

Holding current value

$4.11 Million

Previous $3.72 Million 21.44%

% of portfolio

0.04%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$7.06 - $9.39 $741,045 - $985,611	-104,964 Reduced 21.23%	389,392 $2.92 Million
Q4 2024 Feb 12, 2025	SELL	$7.03 - $8.43 $2.72 Million - $3.26 Million	-386,635 Reduced 43.89%	494,356 $3.72 Million
Q3 2024 Nov 12, 2024	SELL	$6.41 - $8.69 $1 Million - $1.36 Million	-156,180 Reduced 15.06%	880,991 $6.7 Million
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $3.8 Million - $6.25 Million	920,238 Added 786.98%	1,037,171 $6.41 Million
Q1 2024 May 14, 2024	SELL	$4.89 - $7.65 $1.49 Million - $2.33 Million	-304,583 Reduced 72.26%	116,933 $594,000
Q4 2023 Feb 09, 2024	SELL	$4.98 - $6.77 $852,058 - $1.16 Million	-171,096 Reduced 28.87%	421,516 $2.52 Million
Q3 2023 Nov 13, 2023	BUY	$6.71 - $7.92 $1.73 Million - $2.04 Million	257,094 Added 76.63%	592,612 $4.2 Million
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $1.53 Million - $1.93 Million	219,148 Added 188.32%	335,518 $2.36 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $793,126 - $1.18 Million	-99,890 Reduced 46.19%	116,370 $970,000
Q4 2022 Feb 13, 2023	BUY	$10.5 - $14.2 $1.15 Million - $1.56 Million	109,790 Added 103.12%	216,260 $2.48 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $355,616 - $488,107	32,958 Added 44.83%	106,470 $1.34 Million
Q2 2022 Aug 11, 2022	BUY	$7.89 - $17.88 $105,402 - $238,858	13,359 Added 22.21%	73,512 $778,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $695,368 - $1.19 Million	60,153 New	60,153 $978,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $141,225 - $195,290	-12,632 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $105,878 - $131,510	-7,451 Reduced 37.1%	12,632 $182,000
Q2 2021 Aug 12, 2021	BUY	$9.5 - $17.24 $190,788 - $346,230	20,083 New	20,083 $318,000

Others Institutions Holding BCRX

# of Institutions

293

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.96B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Biocryst Pharmaceuticals Inc Transaction History